UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Safety is a key concern for investors. Learn which option, index funds or individual stocks, offers better security for your investments.
24,450 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
QuantumScape reports its first 2025 customer billings and a major monetization milestone, triggering a roughly 5% sto...
Trump signals possible U.S. ground action against Mexican cartels, sending ripples through defense stocks and supply ...
Two lesser-known mining names outside China are surging as Pentagon demand and Western reshoring reshape the rare ear...
U.S. equities moved higher on Thursday as a wave of fresh Wall Street analyst calls buoyed major names across healthc...
Oklo faces a pivotal moment after July. This piece explains a single catalyst investors should watch, the potential s...
SpaceX surged 16% on renewed IPO momentum, while Rocket Lab rose and Virgin Galactic slipped, marking a day of diverg...
Micron, SanDisk, and Western Digital led a roughly 7% slide in memory names Friday as investors lock in gains after a...
Joby Aviation stock surging has a few clear triggers: progress on electric air mobility, a strategic partnership with...
After Johnson Johnson released its latest earnings, investors wonder: is this stock a buy? This guide breaks down the...
Figuring out how much money you need in retirement can feel overwhelming. This guide breaks down a practical, numbers...
Analysts released a wave of Friday calls on major names, lifting some stocks and easing others as markets digest the ...